USO DE VARFARINA EM PEDIATRIA: CARACTERÍSTICAS CLÍNICAS E FARMACOLÓGICAS

USO DE VARFARINA EM PEDIATRIA: CARACTERÍSTICAS CLÍNICAS E FARMACOLÓGICAS

RESUMO Objetivo: Descrever como as crianças respondem à anticoagulação oral com varfarina, verificando a influência da idade, da condição clínica, da via de administração da varfarina e do uso de Nutrição Parenteral Total (NPT), e apresentar a presença de fatores de risco para eventos tromboembóli...

Full description

Bibliographic Details
Main Authors:	Bruna Bergmann Santos, Isabela Heineck, Giovanna Webster Negretto
Format:	Article
Language:	English
Published:	Sociedade de Pediatria de São Paulo 2017-09-01
Series:	Revista Paulista de Pediatria
Subjects:	Warfarin Children Thrombosis Anticoagulants
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822017005007105&lng=en&tlng=en

Similar Items

DOSE NÃO USUAL DE VARFARINA PARA ALCANÇAR RNI TERAPÊUTICA EM UMA CRIANÇA DE QUATRO MESES: FATORES DE RISCO NÃO GENÉTICOS AINDA SÃO UM DESAFIO
by: Lucas Miyake Okumura, et al.

Análise do grau de recanalização da trombose venosa profunda: estudo comparativo de pacientes tratados com varfarina versus rivaroxabana
by: Polyana Klomfass Piati, et al.

Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
by: Jay M. Margolis, et al.
Published: (2016-10-01)

Randomized Comparison of Thrombus Resolution Outcome between Direct Xa Inhibitor Anticoagulant and Warfarin In Acute Deep Vein Thrombosis
by: Jae Hoon Lee, et al.
Published: (2020-11-01)

Thromboembolic recurrence frequency analysis in patients with deep vein thrombosis of lower extremities.
by: Sergyi Vasyliuk, et al.
Published: (2020-03-01)

SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS
by: E. S. Kropacheva
Published: (2016-01-01)

An Assessment of the Effectiveness of Warfarin Therapy Monitoring Systems on Thrombophilic Patients in Zimbabwe
by: Aaron Maramba, et al.
Published: (2018-07-01)

Modern features of the use of anticoagulants in cardiology
by: N. V. Dobryninа
Published: (2018-04-01)

Nível de informação e adesão à terapia de anticoagulação oral com varfarina em pacientes acompanhados em ambulatório de atenção primária à saúde
by: Thais Furtado de Souza, et al.
Published: (2018-06-01)

Improved stacking ensemble learning based on feature selection to accurately predict warfarin dose
by: Mingyuan Wang, et al.
Published: (2024-01-01)

Pharmacogenetic substantiation of personalized prescription of oral anticoagulants in clinical practice
by: K.I. Bentsionova, et al.
Published: (2023-03-01)

Warfarin involvement, in comparison to NOACs, in the development of systemic atherosclerosis
by: Romeo Gabriel Mihaila
Published: (2022-05-01)

Potential factors affecting the anticoagulation control in patients treated with warfarin: Results WARFARIN-TR study
by: Salih Kilic, et al.
Published: (2018-01-01)

Varfarina e femprocumona: experiência de um ambulatório de anticoagulação Warfarina y femprocumona: experiencia de una unidad de anticoagulación Warfarin and phenprocoumon: experience of an outpatient anticoagulation clinic
by: Tiago Luiz Luz Leiria, et al.
Published: (2010-01-01)

Warfarin Toxicity and Individual Variability—Clinical Case
by: Steven Boyages, et al.
Published: (2010-10-01)

Emergency Department Visits due to the Bleeding Complication of Warfarin
by: Bahar Gülcay Çat, et al.
Published: (2020-04-01)

The Effects of 3-Month Rosuvastatin Adjuvant Therapy on Post Thrombotic Syndrome following Deep Vein Thrombosis; a Randomized Clinical Trial
by: Mehdi Pishgahi, et al.
Published: (2023-06-01)

Beyond warfarin: The advent of new oral anticoagulants
by: Sandeep T Laroia, et al.
Published: (2015-10-01)

Efficacy and Safety Profile of Novel Oral Anticoagulants in the Treatment of Left Atrial Thrombosis: A Systematic Review and Meta-Analysis
by: Shu-Jie Dong, MSc, et al.
Published: (2022-01-01)

The progress of prothrombin time measurement
by: Juha Eero Horsti
Published: (2009-12-01)

Assessment of Pharmacists’ Confidence When Consulting Patients on Anticoagulants: A Cross-Sectional Study in Iran
by: Elliyeh Ghadrdan, et al.
Published: (2022-03-01)

Warfarin-Induced Calcification: Potential Prevention and Treatment Strategies
by: Xiaowu Wang, et al.
Published: (2022-09-01)

Warfarin interactions: a letter to editor
by: Sayyed Majid Sadrzadeh, et al.
Published: (2019-10-01)

Enzyme polymorphism in warfarin dose management after pediatric cardiac surgery
by: Avisa Tabib, et al.
Published: (2015-01-01)

Warfarin Resistance, a Case Report
by: Rezayat Parvizi, et al.
Published: (2010-02-01)

Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients
by: MacKay Elizabeth, et al.
Published: (2011-09-01)

ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
by: Amer Rauf, et al.
Published: (2020-12-01)

Warfarin Overdose in a Breast-feeding Woman
by: Schindler, Danielle, et al.
Published: (2011-05-01)

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
by: E. S. Mazur, et al.
Published: (2021-11-01)

The use of apixaban as a perioperative bridge for warfarin in a patient unable to use parenteral anticoagulation: A case report
by: Eric A. Dietrich, et al.
Published: (2021-08-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

Management of warfarin complications in the emergency department
by: Mahmut Özdemir, et al.
Published: (2020-05-01)

CYP2C9*2 and CYP2C9*3 allele variants of CYP2C9 cytochrome gene in St. Petersburg population, and their clinical role in warfarin anticoagulant therapy
by: O. V. Sirotkina, et al.
Published: (2004-12-01)

New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report
by: Francesca Antonia Arcadi, et al.
Published: (2019-03-01)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
by: Krishna N. Pundi, et al.
Published: (2021-12-01)

Determination of Factors that Impact Adherence to Warfarin in Patients with Stroke
by: Zeliha Tülek, et al.
Published: (2019-09-01)

Spontaneous sublingual hematoma secondary to warfarin therapy—A rare complication
by: Aakriti Adhikari, et al.
Published: (2022-12-01)

Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis
by: Jong Yop Pae, et al.
Published: (2022-10-01)

ANTICOAGULANT TREATMENT OF AF: FOCUS ON THE WARFARIN DOSAGE
by: Y. Kovbasniuk, et al.
Published: (2015-10-01)

Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
by: Mu-Mei Hu, et al.
Published: (2017-04-01)